These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 26851736)

  • 41. Improving potency, selectivity, and water solubility of adenosine A1 receptor antagonists: xanthines modified at position 3 and related pyrimido[1,2,3-cd]purinediones.
    Weyler S; Fülle F; Diekmann M; Schumacher B; Hinz S; Klotz KN; Müller CE
    ChemMedChem; 2006 Aug; 1(8):891-902. PubMed ID: 16902942
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Preparation, properties, reactions, and adenosine receptor affinities of sulfophenylxanthine nitrophenyl esters: toward the development of sulfonic acid prodrugs with peroral bioavailability.
    Yan L; Müller CE
    J Med Chem; 2004 Feb; 47(4):1031-43. PubMed ID: 14761205
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Design, synthesis, and biological evaluation of a second generation of pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as potent and selective A2A adenosine receptor antagonists.
    Baraldi PG; Cacciari B; Spalluto G; Bergonzoni M; Dionisotti S; Ongini E; Varani K; Borea PA
    J Med Chem; 1998 Jun; 41(12):2126-33. PubMed ID: 9622554
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis and evaluation of two series of 4'-aza-carbocyclic nucleosides as adenosine A2A receptor agonists.
    Beattie D; Brearley A; Brown Z; Charlton SJ; Cox B; Fairhurst RA; Fozard JR; Gedeck P; Kirkham P; Meja K; Nanson L; Neef J; Oakman H; Spooner G; Taylor RJ; Turner RJ; West R; Woodward H
    Bioorg Med Chem Lett; 2010 Feb; 20(3):1219-24. PubMed ID: 20031406
    [TBL] [Abstract][Full Text] [Related]  

  • 45. N6-methoxy-2-alkynyladenosine derivatives as highly potent and selective ligands at the human A3 adenosine receptor.
    Volpini R; Dal Ben D; Lambertucci C; Taffi S; Vittori S; Klotz KN; Cristalli G
    J Med Chem; 2007 Mar; 50(6):1222-30. PubMed ID: 17309246
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A novel class of adenosine A3 receptor ligands. 1. 3-(2-Pyridinyl)isoquinoline derivatives.
    van Muijlwijk-Koezen JE; Timmerman H; Link R; van der Goot H; IJzerman AP
    J Med Chem; 1998 Oct; 41(21):3987-93. PubMed ID: 9767636
    [TBL] [Abstract][Full Text] [Related]  

  • 47. New A
    Lambertucci C; Spinaci A; Buccioni M; Dal Ben D; Ngouadjeu Ngnintedem MA; Kachler S; Marucci G; Klotz KN; Volpini R
    Bioorg Chem; 2019 Nov; 92():103183. PubMed ID: 31446240
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Design, Synthesis, and Pharmacological Characterization of 2-(2-Furanyl)thiazolo[5,4-d]pyrimidine-5,7-diamine Derivatives: New Highly Potent A
    Varano F; Catarzi D; Vincenzi F; Betti M; Falsini M; Ravani A; Borea PA; Colotta V; Varani K
    J Med Chem; 2016 Dec; 59(23):10564-10576. PubMed ID: 27933962
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis and biological activity of new potential agonists for the human adenosine A2A receptor.
    Bosch MP; Campos F; Niubó I; Rosell G; Díaz JL; Brea J; Loza MI; Guerrero A
    J Med Chem; 2004 Jul; 47(16):4041-53. PubMed ID: 15267242
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 2-Aminothiophene-3-carboxylates and carboxamides as adenosine A1 receptor allosteric enhancers.
    Nikolakopoulos G; Figler H; Linden J; Scammells PJ
    Bioorg Med Chem; 2006 Apr; 14(7):2358-65. PubMed ID: 16314104
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacomodulations around the 4-oxo-1,4-dihydroquinoline-3-carboxamides, a class of potent CB2-selective cannabinoid receptor ligands: consequences in receptor affinity and functionality.
    Stern E; Muccioli GG; Bosier B; Hamtiaux L; Millet R; Poupaert JH; Hénichart JP; Depreux P; Goossens JF; Lambert DM
    J Med Chem; 2007 Nov; 50(22):5471-84. PubMed ID: 17915849
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A
    Basu S; Barawkar DA; Ramdas V; Waman Y; Patel M; Panmand A; Kumar S; Thorat S; Bonagiri R; Jadhav D; Mukhopadhyay P; Prasad V; Reddy BS; Goswami A; Chaturvedi S; Menon S; Quraishi A; Ghosh I; Dusange S; Paliwal S; Kulkarni A; Karande V; Thakre R; Bedse G; Rouduri S; Gundu J; Palle VP; Chugh A; Mookhtiar KA
    Eur J Med Chem; 2017 Feb; 127():986-996. PubMed ID: 27842891
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pyrazolo[1',5':1,6]pyrimido[4,5-d]pyridazin-4(3H)-ones as selective human A(1) adenosine receptor ligands.
    Giovannoni MP; Vergelli C; Cilibrizzi A; Crocetti L; Biancalani C; Graziano A; Dal Piaz V; Loza MI; Cadavid MI; Díaz JL; Gavaldà A
    Bioorg Med Chem; 2010 Nov; 18(22):7890-9. PubMed ID: 20937560
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Design, synthesis, and biological evaluation of novel 2-((2-(4-(substituted)phenylpiperazin-1-yl)ethyl)amino)-5'-N-ethylcarboxamidoadenosines as potent and selective agonists of the A2A adenosine receptor.
    Preti D; Baraldi PG; Saponaro G; Romagnoli R; Aghazadeh Tabrizi M; Baraldi S; Cosconati S; Bruno A; Novellino E; Vincenzi F; Ravani A; Borea PA; Varani K
    J Med Chem; 2015 Apr; 58(7):3253-67. PubMed ID: 25780876
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthesis of substituted N-[3-(3-methoxyphenyl)propyl] amides as highly potent MT(2)-selective melatonin ligands.
    Hu Y; Ho MK; Chan KH; New DC; Wong YH
    Bioorg Med Chem Lett; 2010 Apr; 20(8):2582-5. PubMed ID: 20227878
    [TBL] [Abstract][Full Text] [Related]  

  • 56. 2,3-Dihydro-2-oxo-1H-benzimidazole-1-carboxamides with selective affinity for the 5-HT(4) receptor: synthesis and structure-affinity and structure-activity relationships of a new series of partial agonist and antagonist derivatives.
    Tapia I; Alonso-Cires L; López-Tudanca PL; Mosquera R; Labeaga L; Innerárity A; Orjales A
    J Med Chem; 1999 Jul; 42(15):2870-80. PubMed ID: 10425096
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The second extracellular loop of GPCRs determines subtype-selectivity and controls efficacy as evidenced by loop exchange study at A2 adenosine receptors.
    Seibt BF; Schiedel AC; Thimm D; Hinz S; Sherbiny FF; Müller CE
    Biochem Pharmacol; 2013 May; 85(9):1317-29. PubMed ID: 23500543
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis and biological activity of tricyclic cycloalkylimidazo-, pyrimido- and diazepinopurinediones.
    Drabczyńska A; Yuzlenko O; Köse M; Paskaleva M; Schiedel AC; Karolak-Wojciechowska J; Handzlik J; Karcz T; Kuder K; Müller CE; Kieć-Kononowicz K
    Eur J Med Chem; 2011 Sep; 46(9):3590-607. PubMed ID: 21664729
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The significance of 2-furyl ring substitution with a 2-(para-substituted) aryl group in a new series of pyrazolo-triazolo-pyrimidines as potent and highly selective hA(3) adenosine receptors antagonists: new insights into structure-affinity relationship and receptor-antagonist recognition.
    Cheong SL; Dolzhenko A; Kachler S; Paoletta S; Federico S; Cacciari B; Dolzhenko A; Klotz KN; Moro S; Spalluto G; Pastorin G
    J Med Chem; 2010 Apr; 53(8):3361-75. PubMed ID: 20307065
    [TBL] [Abstract][Full Text] [Related]  

  • 60. 1,2,4-triazolo[1,5-a]quinoxaline derivatives and their simplified analogues as adenosine A₃ receptor antagonists. Synthesis, structure-affinity relationships and molecular modeling studies.
    Catarzi D; Varano F; Poli D; Squarcialupi L; Betti M; Trincavelli L; Martini C; Dal Ben D; Thomas A; Volpini R; Colotta V
    Bioorg Med Chem; 2015 Jan; 23(1):9-21. PubMed ID: 25497490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.